General information about COVID-19 antivirals treatments
Consultations can be requested using the links below based on the state of residence:
Paxlovid or Molnupiravir are intended for those with mild to moderate COVID-19 who are at high-risk for progression to severe COVID-19, and who are within 5 days of symptom onset. Molnupiravir is only for patients for whom other COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate. Learn more about Paxlovid on the manufacturer’s website, and review the patient and healthcare provider fact sheets for more information. Learn more about Molnupiravir on the manufacturer’s website, and review the patient and healthcare provider factsheets.
People that have been exposed to someone diagnosed to COVID-19, or if it is unknown if they have been exposed to someone diagnosed with COVID-19, they may be eligible for a consult. Pregnant individuals will also be eligible for a consultation if they reside in Massachusetts, Washington, Oregon or Wisconsin.
A virtual visit for COVID-19 antiviral treatment is available to adults and children 12 years and older.
A parent or guardian is required to register someone aged 12 to 18 years old. A parent/guardian must create an account and add a dependent. A parent/guardian can then request a visit for their dependent. If the visit is for your child or adult dependent, you’ll both need to be present to see the clinician. Eligibility may also be restricted depending on your Color program sponsor’s terms. Eligibility through Color’s partnerships with Massachusetts, Washington, Oregon and Wisconsin is limited to persons who are currently located in those states, and pharmacy products are only shipped to valid addresses in Massachusetts, Washington, Oregon and Wisconsin.
Clinicians will be evaluating whether a patient should be given a prescription for the COVID-19 antiviral treatments Paxlovid or Molnupiravir. If you are interested in other treatment options for COVID-19, please seek care from your healthcare provider.
Paxlovid has not been approved, but has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS CoV-2 viral testing, and who are at high-risk for progression to severe COVID-19, including hospitalization or death.
If Paxlovid is appropriate, treatment should be initiated as soon as possible after COVID-19 diagnosis and within 5 days of symptom onset. Paxlovid is not for people that have a history of allergy to nirmatrelvir or ritonavir or other components of these drugs, and it is not for people taking certain other drugs. Paxlovid may cause side effects, some of which may be serious and unexpected. Learn more about Paxlovid on the manufacturer’s website, at https://www.covid19oralrx-patient.com, and review the patient and healthcare provider fact sheets for more information.
The emergency use of Paxlovid is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.
Molnupiravir is authorized for emergency use by FDA under an EUA to treat mild-to-moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate.
Molnupiravir isn’t authorized for use in people less than 18 years of age, for prevention of COVID-19, for people needing hospitalization for COVID-19, or for use for longer than 5 consecutive days. Molnupiravir isn’t recommended for use in pregnancy as it may cause harm to an unborn baby. Molnupiravir may cause side effects, some of which may be serious and unexpected. Learn more about Molnupiravir on the manufacturer’s website and review the patient and healthcare provider fact sheets for more information.
The emergency use of Molnupiravir is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.
Trademarks referenced herein held by their respective owners.
Your clinician visit is free and will not be charged by insurance. Depending on your insurance, you may be responsible for costs associated with an antivirals prescription you receive. For patients with Medicare, Medicaid, other government insurance programs, or without insurance, enroll in the PAXCESS™ patient support program or call (877) 219-7225 to verify your information for no cost share.
For patients with Commercial insurance, enroll in the PAXCESS™ co-pay savings program or call (877) 219-7225 to receive cost savings on your co-pay.
Consultations can be requested using the links below based on the state of residence:
Paxlovid or Molnupiravir are intended for those with mild to moderate COVID-19 who are at high-risk for progression to severe COVID-19, and who are within 5 days of symptom onset. Molnupiravir is only for patients for whom other COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate. Learn more about Paxlovid on the manufacturer’s website, and review the patient and healthcare provider fact sheets for more information. Learn more about Molnupiravir on the manufacturer’s website, and review the patient and healthcare provider factsheets.
People that have been exposed to someone diagnosed to COVID-19, or if it is unknown if they have been exposed to someone diagnosed with COVID-19, they may be eligible for a consult. Pregnant individuals will also be eligible for a consultation if they reside in Massachusetts, Washington, Oregon or Wisconsin.
A virtual visit for COVID-19 antiviral treatment is available to adults and children 12 years and older.
A parent or guardian is required to register someone aged 12 to 18 years old. A parent/guardian must create an account and add a dependent. A parent/guardian can then request a visit for their dependent. If the visit is for your child or adult dependent, you’ll both need to be present to see the clinician. Eligibility may also be restricted depending on your Color program sponsor’s terms. Eligibility through Color’s partnerships with Massachusetts, Washington, Oregon and Wisconsin is limited to persons who are currently located in those states, and pharmacy products are only shipped to valid addresses in Massachusetts, Washington, Oregon and Wisconsin.
Clinicians will be evaluating whether a patient should be given a prescription for the COVID-19 antiviral treatments Paxlovid or Molnupiravir. If you are interested in other treatment options for COVID-19, please seek care from your healthcare provider.
Paxlovid has not been approved, but has been authorized for emergency use by FDA under an EUA, for the treatment of mild-to-moderate COVID-19 in adults and pediatric patients (12 years of age and older weighing at least 40 kg) with positive results of direct SARS CoV-2 viral testing, and who are at high-risk for progression to severe COVID-19, including hospitalization or death.
If Paxlovid is appropriate, treatment should be initiated as soon as possible after COVID-19 diagnosis and within 5 days of symptom onset. Paxlovid is not for people that have a history of allergy to nirmatrelvir or ritonavir or other components of these drugs, and it is not for people taking certain other drugs. Paxlovid may cause side effects, some of which may be serious and unexpected. Learn more about Paxlovid on the manufacturer’s website, at https://www.covid19oralrx-patient.com, and review the patient and healthcare provider fact sheets for more information.
The emergency use of Paxlovid is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.
Molnupiravir is authorized for emergency use by FDA under an EUA to treat mild-to-moderate COVID-19 in adults with positive results of direct SARS-CoV-2 viral testing, and who are at high risk for progression to severe COVID-19 including hospitalization or death, and for whom other COVID-19 treatment options approved or authorized by the FDA are not accessible or clinically appropriate.
Molnupiravir isn’t authorized for use in people less than 18 years of age, for prevention of COVID-19, for people needing hospitalization for COVID-19, or for use for longer than 5 consecutive days. Molnupiravir isn’t recommended for use in pregnancy as it may cause harm to an unborn baby. Molnupiravir may cause side effects, some of which may be serious and unexpected. Learn more about Molnupiravir on the manufacturer’s website and review the patient and healthcare provider fact sheets for more information.
The emergency use of Molnupiravir is only authorized for the duration of the declaration that circumstances exist justifying the authorization of the emergency use of drugs and biological products during the COVID-19 pandemic under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb3(b)(1), unless the declaration is terminated or authorization revoked sooner.
Trademarks referenced herein held by their respective owners.
Your clinician visit is free and will not be charged by insurance. Depending on your insurance, you may be responsible for costs associated with an antivirals prescription you receive. For patients with Medicare, Medicaid, other government insurance programs, or without insurance, enroll in the PAXCESS™ patient support program or call (877) 219-7225 to verify your information for no cost share.
For patients with Commercial insurance, enroll in the PAXCESS™ co-pay savings program or call (877) 219-7225 to receive cost savings on your co-pay.
What to expect from a scheduled virtual visit
Your visit will be performed by a clinician from one of our partner networks. They ensure that their clinicians possess the credentials, training, licensing, experience, and competence to provide high-quality and cost-effective care.
If you scheduled a video visit, you will be placed in a queue and your clinician will send a text message with a link to join the video consultation at the scheduled time. This link can also be found on your Color account dashboard.
The video call will take about 10 minutes. If the clinician cannot complete a video call with you, they will not be able to complete your evaluation.
When you schedule a phone visit, you will be placed in a queue and your clinician will call you after they review your information. Prior to the phone consultation, you will receive a notification that you will receive the call soon. For more details visit your Color account dashboard.
How do I cancel or reschedule my visit?
To cancel or reschedule your visit, contact Support by email at treatments@color.com or call at (844) 352-6567 from 8 AM to 8 PM EST, 7 days a week. You may also cancel your appointment through your Color account dashboard
For video visits, a clinician will wait up to 10 minutes for you to join the video call. If the clinician cannot complete a video call with you, they will not be able to complete your evaluation. If you miss the visit, you can call Support at (844) 352-6567 and request a new visit.
For phone visits, If you don’t answer the first call, the clinician will attempt to call you one more time within 10 minutes. If you miss both calls, you can call Support at (844) 352-6567 and request a new visit.
Antivirals visits are available in:
- English
- Spanish
- Portuguese
- Haitian Creole
- Mandarin Chinese (simplified)
- Mandarin Chinese (traditional)
- Tagalog/Filipino
- Russian
- Somali
- French
- Korean
Your visit will be performed by a clinician from one of our partner networks. They ensure that their clinicians possess the credentials, training, licensing, experience, and competence to provide high-quality and cost-effective care.
If you scheduled a video visit, you will be placed in a queue and your clinician will send a text message with a link to join the video consultation at the scheduled time. This link can also be found on your Color account dashboard.
The video call will take about 10 minutes. If the clinician cannot complete a video call with you, they will not be able to complete your evaluation.
When you schedule a phone visit, you will be placed in a queue and your clinician will call you after they review your information. Prior to the phone consultation, you will receive a notification that you will receive the call soon. For more details visit your Color account dashboard.
How do I cancel or reschedule my visit?
To cancel or reschedule your visit, contact Support by email at treatments@color.com or call at (844) 352-6567 from 8 AM to 8 PM EST, 7 days a week. You may also cancel your appointment through your Color account dashboard
For video visits, a clinician will wait up to 10 minutes for you to join the video call. If the clinician cannot complete a video call with you, they will not be able to complete your evaluation. If you miss the visit, you can call Support at (844) 352-6567 and request a new visit.
For phone visits, If you don’t answer the first call, the clinician will attempt to call you one more time within 10 minutes. If you miss both calls, you can call Support at (844) 352-6567 and request a new visit.
Antivirals visits are available in:
- English
- Spanish
- Portuguese
- Haitian Creole
- Mandarin Chinese (simplified)
- Mandarin Chinese (traditional)
- Tagalog/Filipino
- Russian
- Somali
- French
- Korean
Pharmacy options and prescriptions
Local Pharmacy Pickup
It is recommended to confirm with your pharmacy that Paxlovid is in stock as well as their operating hours prior to submitting the health questionnaire. This will ensure your consultation will be completed in a timely manner.
Do you need home delivery?
If you need home delivery, please follow up with your selected pharmacy to discuss options. If you are on a Medicaid or Medicare insurance plan or do not have health insurance, you may be eligible for free overnight delivery. Call AssistRx at (877) 450-4412 to learn more.
Check with your pharmacy if they can transfer the prescription to the new pharmacy. If your pharmacy can not be reached, it is recommended to contact the new pharmacy you plan to transfer the Rx to and attempt the transfer from there.
If a transfer is needed, please provide the pharmacy details (address and phone number) and confirm with the pharmacy that Paxlovid is in stock. If you encounter any issue, contact treatments@color.com and we will assist with the transfer.
Local Pharmacy Pickup
It is recommended to confirm with your pharmacy that Paxlovid is in stock as well as their operating hours prior to submitting the health questionnaire. This will ensure your consultation will be completed in a timely manner.
Do you need home delivery?
If you need home delivery, please follow up with your selected pharmacy to discuss options. If you are on a Medicaid or Medicare insurance plan or do not have health insurance, you may be eligible for free overnight delivery. Call AssistRx at (877) 450-4412 to learn more.
Check with your pharmacy if they can transfer the prescription to the new pharmacy. If your pharmacy can not be reached, it is recommended to contact the new pharmacy you plan to transfer the Rx to and attempt the transfer from there.
If a transfer is needed, please provide the pharmacy details (address and phone number) and confirm with the pharmacy that Paxlovid is in stock. If you encounter any issue, contact treatments@color.com and we will assist with the transfer.
What to expect from the COVID-19 Antiviral Treatment Hotline?
No, you do not need a Color account to use the antiviral hotline. If at a later date you would like to see your after-visit summary, you may create an account and link them together or request a copy from Color. Providing an email address is optional, however it is recommended to receive the after-visit summary. If you need assistance with your after-visit-summary, please contact us at treatments@color.com
Your virtual visit will be with a licensed clinician from one of our partner networks.
When you schedule a phone visit, you’ll be placed in a queue and your clinician will attempt to call you after they review your information. You should receive a notification notifying you that a clinician will call soon, more details can be found on your Color account dashboard. If you don’t answer the first call, the clinician will attempt to call you one more time within 10 minutes. If you miss both calls, you can call Support at (844) 352-6567 and request a new visit. Note: depending on your phone carrier the phone number might appear to be from an unknown caller.
To cancel your visit or schedule another visit, you may do so from your Color account dashboard by clicking “Cancel Consultation”, from there you may contact Support by emailing treatments@color.com or calling Support at (844) 352-6567, 7 days a week, for assistance.
If you don’t answer the first call, the clinician will call you one more time in the next 10 minutes. If the clinician can’t reach you after two calls, they won’t be able to complete your visit and you will have to request a new consultation. The caller ID might read as “unknown caller”. If enabled, please disable any spam blockers on your phone to ensure the clinician can reach you. If you miss the calls, please call (833) 273-6330 and request a new visit.
No. At this time, visit requests can only be made for dependents through the online flow.
Antivirals visits are available in:
- English
- Spanish
- Portuguese
- Haitian Creole
- Mandarin Chinese (simplified)
- Mandarin Chinese (traditional)
- Tagalog/Filipino
- Russian
- Somali
- French
- Korean
- Vietnamese
- Amharic
- Marshallese
- Arabic
- Hmong
You can review versions of the documentation collected during intake here:
No, you do not need a Color account to use the antiviral hotline. If at a later date you would like to see your after-visit summary, you may create an account and link them together or request a copy from Color. Providing an email address is optional, however it is recommended to receive the after-visit summary. If you need assistance with your after-visit-summary, please contact us at treatments@color.com
Your virtual visit will be with a licensed clinician from one of our partner networks.
When you schedule a phone visit, you’ll be placed in a queue and your clinician will attempt to call you after they review your information. You should receive a notification notifying you that a clinician will call soon, more details can be found on your Color account dashboard. If you don’t answer the first call, the clinician will attempt to call you one more time within 10 minutes. If you miss both calls, you can call Support at (844) 352-6567 and request a new visit. Note: depending on your phone carrier the phone number might appear to be from an unknown caller.
To cancel your visit or schedule another visit, you may do so from your Color account dashboard by clicking “Cancel Consultation”, from there you may contact Support by emailing treatments@color.com or calling Support at (844) 352-6567, 7 days a week, for assistance.
If you don’t answer the first call, the clinician will call you one more time in the next 10 minutes. If the clinician can’t reach you after two calls, they won’t be able to complete your visit and you will have to request a new consultation. The caller ID might read as “unknown caller”. If enabled, please disable any spam blockers on your phone to ensure the clinician can reach you. If you miss the calls, please call (833) 273-6330 and request a new visit.
No. At this time, visit requests can only be made for dependents through the online flow.
Antivirals visits are available in:
- English
- Spanish
- Portuguese
- Haitian Creole
- Mandarin Chinese (simplified)
- Mandarin Chinese (traditional)
- Tagalog/Filipino
- Russian
- Somali
- French
- Korean
- Vietnamese
- Amharic
- Marshallese
- Arabic
- Hmong
You can review versions of the documentation collected during intake here:
After your visit
Your visit details can be accessed from your Visits tab at home.color.com. You can take a screenshot of your visit details page or print from your browser. If you are unable to view your aftercare plan, please contact us at treatments@color.com and we can email you the after care plan.
Are you able to write a sick slip, work excuse, or return-to-work note?
Although patients will receive a treatment plan, we are unable to write a sick slip, work excuse, or return-to-work note.
If you have questions, you can email treatments@color.com or call (844) 352-6567 7 days a week.
A medication fact sheet link is available as part of your treatment after care summary. If you experience adverse reactions, please contact your local emergency services or call 911. Color Support is unable to answer any clinical questions or concerns.
Any clinical questions you may have should be directed to your personal care physician or a medical care professional. Color Support is unable to provide clinical advice under any circumstances.
Your visit details can be accessed from your Visits tab at home.color.com. You can take a screenshot of your visit details page or print from your browser. If you are unable to view your aftercare plan, please contact us at treatments@color.com and we can email you the after care plan.
Are you able to write a sick slip, work excuse, or return-to-work note?
Although patients will receive a treatment plan, we are unable to write a sick slip, work excuse, or return-to-work note.
If you have questions, you can email treatments@color.com or call (844) 352-6567 7 days a week.
A medication fact sheet link is available as part of your treatment after care summary. If you experience adverse reactions, please contact your local emergency services or call 911. Color Support is unable to answer any clinical questions or concerns.
Any clinical questions you may have should be directed to your personal care physician or a medical care professional. Color Support is unable to provide clinical advice under any circumstances.
Contact Us
Email: treatments@color.com
Call: (844) 352-6567
Hours: 5 AM to 5 PM PT (8 AM to 8 PM ET), 7 days a week.
